Related Experiment Video
Updated: Mar 8, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules
Erica Di Cesare1, Annalisa Verrico1, Andrea Miele1,2
1Institute of Molecular Biology and Pathology, CNR National Research Council, c/o Department of Biology and Biotechnology, Sapienza Università di Roma, Roma, Italy.
Abstract:
Tubulin-targeting molecules are widely used cancer therapeutic agents. They inhibit microtubule-based structures, including the mitotic spindle, ultimately preventing cell division. The final fates of microtubule-inhibited cells are however often heterogeneous and difficult to predict. While recent work has provided insight into the cell response to inhibitors of microtubule dynamics (taxanes), the cell response to tubulin polymerization inhibitors remains less well characterized. Arylthioindoles (ATIs) are recently developed tubulin inhibitors. We previously identified ATI members that effectively inhibit tubulin polymerization in vitro and cancer cell growth in bulk cell viability assays. Here we characterise in depth the response of cancer cell lines to five selected ATIs. We find that all ATIs arrest mitotic progression, yet subsequently yield distinct cell fate profiles in time-lapse recording assays, indicating that molecules endowed with similar tubulin polymerization inhibitory activity in vitro can in fact display differential efficacy in living cells. Individual ATIs induce cytological phenotypes of increasing severity in terms of damage to the mitotic apparatus. That differentially triggers MCL-1 down-regulation and caspase-3 activation, and underlies the terminal fate of treated cells. Collectively, these results contribute to define the cell response to tubulin inhibitors and pinpoint potentially valuable molecules that can increase the molecular diversity of tubulin-targeting agents.
Insights
Arylthioindoles (ATIs) are novel tubulin polymerization inhibitors that arrest cancer cell division. These compounds display distinct efficacies and cellular fates, offering diverse therapeutic potential beyond current tubulin-targeting agents.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Tubulin-targeting agents are crucial in cancer therapy, inhibiting cell division by disrupting microtubule structures.
- The cellular response to tubulin polymerization inhibitors is less understood compared to microtubule dynamics inhibitors.
- Arylthioindoles (ATIs) are a novel class of tubulin inhibitors with demonstrated anti-cancer activity.
Purpose of the Study:
- To comprehensively characterize the cellular response of cancer cell lines to five selected arylthioindoles (ATIs).
- To investigate the differential efficacy and cell fate outcomes induced by ATIs with similar in vitro polymerization inhibitory activity.
- To elucidate the molecular mechanisms underlying ATI-induced cell death, including mitotic apparatus damage, MCL-1 down-regulation, and caspase-3 activation.
Main Methods:
- In vitro tubulin polymerization assays.
- Cancer cell line viability assays.
- Time-lapse microscopy for cell fate profiling.
- Cytological analysis of mitotic apparatus.
- Western blotting for MCL-1 and caspase-3 activation.
Main Results:
- All tested ATIs effectively inhibited tubulin polymerization and arrested mitotic progression in cancer cells.
- Distinct cell fate profiles were observed among ATIs, despite similar in vitro activity, highlighting differential in vivo efficacy.
- ATIs induced varying degrees of mitotic apparatus damage, correlating with MCL-1 down-regulation and caspase-3 activation, determining cell death.
- The study identified specific ATIs with distinct cytological phenotypes and downstream signaling events.
Conclusions:
- Arylthioindoles exhibit diverse cellular responses and efficacies, offering a broader spectrum of tubulin-targeting cancer therapies.
- Differential damage to the mitotic apparatus and subsequent apoptotic signaling pathways dictate the terminal cell fate.
- These findings expand the understanding of tubulin inhibitor mechanisms and identify promising candidates for novel anti-cancer drug development.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Inhibition of Cdk Activity
Microtubule Instability
The Intrinsic Apoptotic Pathway

